UBS raised the firm’s price target on Intuitive Surgical (ISRG) to $585 from $547 and keeps a Neutral rating on the shares. The180 da Vinci 5 placements in Q2, higher than the 147 in Q1, signals meaningful adoption that should be enough for shares to hold at current levels, the analyst tells investors in a research note. UBS remains on the sidelines given the uncertainty of these unprecedented times in regards to healthcare and trade policy.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $571 from $566 at BTIG
- Intuitive Surgical price target raised to $595 from $575 at Piper Sandler
- Intuitive Surgical: Strong Performance and Promising Growth Prospects Justify Buy Rating
- Intuitive Surgical’s Strong Performance and Growth Prospects Justify Buy Rating
- Intuitive Surgical price target raised to $599 from $559 at Wells Fargo